High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

Background/Aims The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited. The risk of TB reactivation on IFX and its predictors in patients with IBD was assessed. Methods This retr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Association for the Study of Intestinal Diseases 2018-10-01
coleção:	Intestinal Research
Assuntos:	Colitis, ulcerative Crohn disease Latent tuberculosis Mantoux Interferon-gamma release tests
Acesso em linha:	http://www.irjournal.org/upload/pdf/ir-2018-00023.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!